Are there clinical and lab parameters that predict the outcome of hepatobiliary scintigraphy (HBS) in acute cholecystitis?

Updated: May 20, 2021
  • Author: Alan A Bloom, MD; Chief Editor: BS Anand, MD  more...
  • Print
Answer

A retrospective study by Singer et al, aimed at determining a set of clinical and laboratory parameters that could be used to predict the outcome of hepatobiliary scintigraphy (HBS) in patients with suspected acute cholecystitis, found that of the 40 patients with pathologically confirmed acute cholecystitis, 36 (90%) did not have fever at the time of presentation and 16 (40%) did not have leukocytosis. [20] The study also found that no combination of laboratory or clinical values was useful in identifying patients at a high risk for a positive HBS finding.


Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!